{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Dublin",
      "state": "OH",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "BLA125469"
        ],
        "brand_name": [
          "TRULICITY"
        ],
        "generic_name": [
          "DULAGLUTIDE"
        ],
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "product_ndc": [
          "0002-3182",
          "0002-1433",
          "0002-1434",
          "0002-2236"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "DULAGLUTIDE"
        ],
        "rxcui": [
          "1551295",
          "1551300",
          "1551304",
          "1551306",
          "2395777",
          "2395779",
          "2395783",
          "2395785"
        ],
        "spl_id": [
          "16dbc870-9954-4989-b370-78bb3520a038"
        ],
        "spl_set_id": [
          "463050bd-2b1c-40f5-b3c3-0a04bb433309"
        ],
        "package_ndc": [
          "0002-1433-01",
          "0002-1433-80",
          "0002-1433-61",
          "0002-1434-01",
          "0002-1434-80",
          "0002-1434-61",
          "0002-2236-01",
          "0002-2236-80",
          "0002-2236-61",
          "0002-3182-01",
          "0002-3182-80",
          "0002-3182-61"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000178480",
          "M0160181",
          "N0000020058"
        ],
        "pharm_class_epc": [
          "GLP-1 Receptor Agonist [EPC]"
        ],
        "pharm_class_cs": [
          "Glucagon-Like Peptide 1 [CS]"
        ],
        "pharm_class_moa": [
          "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"
        ],
        "unii": [
          "WTT295HSY5"
        ]
      },
      "product_type": "Drugs",
      "event_id": "89976",
      "recalling_firm": "Cardinal Health Inc.",
      "address_1": "7000 Cardinal Pl",
      "address_2": "N/A",
      "postal_code": "43017-1091",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "NM only",
      "recall_number": "D-0884-2022",
      "product_description": "Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only,  Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80",
      "product_quantity": "1 box",
      "reason_for_recall": "TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions",
      "recall_initiation_date": "20220405",
      "center_classification_date": "20220519",
      "report_date": "20220525",
      "code_info": "Lot #: D484557A, Exp: 10/25/2023.",
      "more_code_info": ""
    }
  ]
}